The study focuses on the molecular processes in wound healing that regulate the transition from inflammation – a critical ...

The different phases of the menstrual cycle have fluctuating hormones that impact mood, energy and more. Here's how to eat ...

Conversely, inappropriate treatments for the stage of pathology (such as “loading up” of a tendon in the proliferative phase of tendinopathy) may increase pain, leading to a poor clinical outcome.40 ...

Department of Physiology, Division of Life Science, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan ...

The company will seek a strategic partner to continue development of APX3330, an oral small-molecule inhibitor of Ref-1 for ...

A new study has identified an RNA molecule that is important for skin wound healing. The research may have implications for the treatment of hard-to-heal wounds. A new study from Karolinska ...

Eye drug maker Ocuphire Pharma is acquiring gene therapy developer Opus Genetics in an all-stock transaction that will see ...

Endocrine Neoplasia Translational Research Center, Division of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, and Tel Aviv University Faculty of Medicine, Ramat Gan, Israel This ...

Acquisition creates a leading, clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations New OPGx-LCA5 Phase 1/2 6-month data demonstrate sa ...

Kodiak Sciences KOD is a clinical-stage biopharmaceutical company engaged in developing novel therapeutics to treat chronic and high-prevalence retinal diseases, which are the major causes of ...

The final patient completing our pivotal F351 Phase 3 trial marks an important milestone for Gyre and our development pipeline. We are grateful to the patients, researchers, trial investigators, and ...

Besides this, these were patients who had proliferative refractory disease ... myeloma [r/r MM], it is in the process of running a phase 1/1b trial. This particular study is expected to recruit ...